Stock News

WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion

0

Shares of Global Blood Therapeutics Inc.
GBT,
+38.88%

jumped 9.5% in trading on Friday after The Wall Street Journal reported that Pfizer Inc.
PFE,
-0.94%

is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Therapeutics, which markets a sickle-cell treatment, is attracting takeover interest. The company’s stock is up 79.6% this year, while the broader S&P 500
SPX,
-0.64%

is down 12.8%.

Bed Bath & Beyond is discontinuing a private brand as it tries to reverse declining sales

Previous article

Here’s Why Rich Americans Are Moving Here

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Stock News